PrimeRFP SCOUT · Federal Contract Recompete Brief

36C26222C0145Radiopharmaceutical supplies-netspot (gallium — Jubilant Draximage Inc

Jubilant Draximage Inc holds $2.1M across 11 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 1 related award in the incumbent pipeline. Competition previously drew 2 offers. Set-aside status: NONE. Recompete timing centers on the Jul 21, 2027 PoP end — agencies typically plan 12–18 months ahead.

262-Network Contract Office 22 (36C262)

Awarding office

Jubilant Draximage Inc

Recipient

Jul 21, 2027

PoP end

$442K

Obligated

$604K

Potential

325412

NAICS

6525

PSC

NONE

Set-aside

2 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Jubilant Draximage Inc — $90

Contract facts

NONE

Contract number36C26222C0145

Also listed as36C262-22-C-0145

Agency262-Network Contract Office 22 (36C262)

Awarding office262-Network Contract Office 22 (36C262)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentJubilant Draximage Inc

CAGEL02J7

UEIM3XTBYTERVN5

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6525

Place of performanceLOMA LINDA CA

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startJul 22, 2022

PoP end (current)Jul 21, 2027

PoP end (w/ options)Jul 31, 2027

Obligated$442K

Current value$520K

Potential value$604K

RADIOPHARMACEUTICAL SUPPLIES-NETSPOT (GALLIUM 68 DOTATATE) is a federal NONE award for 262-Network Contract Office 22 (36C262) held by Jubilant Draximage Inc. Estimated value $604K ($442K obligated). Current period of performance ends Jul 21, 2027 (potential Jul 31, 2027). Last award drew 2 bidders. Place of performance: LOMA LINDA CA.

RADIOPHARMACEUTICAL SUPPLIES-NETSPOT (GALLIUM 68 DOTATATE)

Recompete timing

Public

● Expiring in 334 days

Current PoP ends Jul 21, 2027 (334 days remaining). Agencies typically plan 12–18 months ahead — at 11.0 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Jubilant Draximage Inc — $2.1M obligated across 11 awards (firm-wide, all agencies).

Sole agency: Department of Veterans Affairs (VA)

Department of Veterans Affairs (VA)$2.1M · 100% of firm total

Open full company profile →

Related awards

Same incumbent

36C25026N0010

RADIOACTIVE ISOTOPES

$600K

Sep 30, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C26222C0145?

36C26222C0145 (Radiopharmaceutical supplies-netspot (gallium) is a 262-Network Contract Office 22 (36C262) award with a potential value of $604K, currently held by Jubilant Draximage Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C262-22-C-0145?

36C262-22-C-0145 is the dashed form of PIID 36C26222C0145 (Radiopharmaceutical supplies-netspot (gallium), held by Jubilant Draximage Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C26222C0145?

262-Network Contract Office 22 (36C262) awarded 36C26222C0145 to Jubilant Draximage Inc (potential $604K).

Who is the incumbent on 36C26222C0145?

Jubilant Draximage Inc is the incumbent with $2.1M across 11 related awards in SCOUT’s public footprint. The current period of performance ends Jul 21, 2027.

When does Jubilant Draximage Inc’s 36C26222C0145 come up for recompete?

SCOUT tracks a period-of-performance end of Jul 21, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 25, 2026 · refreshed monthlyLatest procurement action Jul 13, 2026